The U.S. Centers for Disease Control and Prevention (CDC) is increasing its emergency response efforts as the Ebola outbreak in the Democratic Republic of the Congo and Uganda continues to worsen. According to an internal email obtained by Reuters, the agency has asked employees to volunteer for urgent deployment to assist with Ebola screening operations at U.S. entry points.
CDC Acting Director Jay Bhattacharya stated that the agency activated a Level 2 emergency response on May 18 following the spread of the Bundibugyo strain of the Ebola virus. The move reflects growing concern over the outbreak, which the World Health Organization (WHO) has labeled the third-largest Bundibugyo Ebola outbreak ever recorded.
As part of the enhanced response, the CDC is expanding recruitment beyond its traditional emergency response teams. Additional staff, including public health advisers, emergency specialists, and licensed medical providers, are being encouraged to participate with supervisor approval.
The screening operations are already active at several U.S. port health stations. Volunteers may be responsible for monitoring international travelers for Ebola symptoms, conducting temperature checks, and referring suspected cases for further medical evaluation.
The Bundibugyo strain of Ebola is a rare but highly dangerous virus spread through direct contact with infected bodily fluids. Ebola symptoms can include fever, fatigue, vomiting, bleeding, and severe weakness. Health experts warn that rapid identification and containment are critical to preventing wider transmission.
WHO Director-General Tedros Adhanom Ghebreyesus recently warned that the fast-moving outbreak is outpacing current response efforts in Africa. The latest reports indicate that at least 220 suspected deaths have been linked to the outbreak in Congo and Uganda.
The CDC’s expanded airport screening measures highlight growing international concern over the Ebola crisis and the need to strengthen global public health preparedness in 2026.


FDA Investigates New Cyclospora Outbreak as U.S. Cases Continue to Rise
Novo Nordisk Eyes Turnaround as Oral Wegovy Challenges Eli Lilly in Weight-Loss Drug Race
SEC Moves to Dismiss Insider Trading Case Against Trump-Pardoned Terren Peizer
AstraZeneca Shares Sink After Wainua Trial Misses Key Heart Disease Goal
Senate Majority Leader John Thune Moves to Advance Crypto Clarity Act
Trump Orders Reduction in U.S.-South Korea Military Drills, Citing Kim Jong Un Ties
Should I take zinc or eat oysters to ward off colds, boost my immune system or improve fertility?
New Zealand Moves to Ban Social Media for Children Under 16
Venezuela Earthquake Health Risks Rise as Disease Monitoring Intensifies
FAA to Pause Reagan National Airport Flights for Freedom 250 IndyCar Race
US Sailor’s Father Detained by Immigration Authorities
US Tightens Cuba Sanctions, Targets Officials and State Entities
Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Trump Orders Probe Into Pentagon Munitions Stockpile Leaks After Iran Conflict
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 



